Faraz Arkam

Dr. Faraz Arkam

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
AKAbdullah Khan
Abdullah Khan
FAFaraz Arkam
Faraz Arkam
FDFaisal S. Dar
Faisal S. Dar
MKMuhammad Khan
Muhammad Khan
ABAbu Bakar Hafeez Bhatti
Abu Bakar Hafeez Bhatti

1 January 2025 in Anesthesiology Research and Practice
Verified
Journal Article
Open access
MJMohammad Jawwad
Mohammad Jawwad
DDDawar Nadeem Aslam Dar
Dawar Nadeem Aslam Dar
RKRana Faheem Ullah Khan
Rana Faheem Ullah Khan
ACAizaz Chaudhry
Aizaz Chaudhry
FAFaraz Arkam
Faraz Arkam
PPPierina Clementine Pereira
Pierina Clementine Pereira
Background: Pain management is an integral part of recovery after major abdominal surgeries. Traditionally, epidural analgesia is used for postoperative pain management in major abdominal surgeries. However, intravenous lidocaine has recently been proven to be a good alternative. However, there is very limited evidence comparing their efficacy in major abdominal surgery. The aim of this review is to compare the effectiveness of epidural analgesia with intravenous lidocaine in reducing pain and opioid consumption following major abdominal surgery. Methods: We searched PubMed and Cochrane Library from inception to May 2024 to identify studies that match our topic. We performed all statistical analyses using RevMan. The primary outcome was pain scores. The other outcomes were opioid requirements, postoperative nausea and vomiting, hospital stay duration, and time to pass flatus. Results: Seven studies (six randomized clinical trials and one observational study; n = 643) were included. Our results suggest that epidural bupivacaine significantly reduced pain scores during the first 24 h postoperatively as compared with the patients who received intravenous lidocaine (Std. mean difference: −0.23; 95% confidence interval [CI]: −0.40, −0.06; and p = 0.008). There was no difference at 48 h (Std. mean difference: −0.09; 95% CI: −0.27, 0.08; and p = 0.028) and 72 h intervals (Std. mean difference: −0.08; 95% CI: −0.25, 0.09; and p = 0.037). Conclusion: Our study shows that epidural analgesia, particularly epidural bupivacaine, provides superior pain relief as compared to intravenous lidocaine during the first 24 h postoperatively. However, there was heterogeneity among studies. Thus, in future, large standardized randomized controlled trials are required.

9 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SYSalim Yakdan
Salim Yakdan
KJKaran Joseph Karan Joseph
Karan Joseph Karan Joseph
JZJingyi University of Science and Zhang
Jingyi University of Science and Zhang
MRMiguel A Ruiz-Cardozo
Miguel A Ruiz-Cardozo
APAryan Pradhan
Aryan Pradhan
JGJacob K. Greenberg
Jacob K. Greenberg
Study Design: Retrospective Case–Control. Objectives: Sleep disturbances negatively impact quality of life and increase illness susceptibility. Chronic pain is a risk factor for sleep disruption, particularly in patients with degenerative spinal conditions. Existing studies suggest that degenerative cervical myelopathy (DCM) patients often experience sleep disturbances, possibly due to spinal cord compression and pain. However, most research is limited to small, single-center studies, creating a need for broader analyses. Methods: We utilized the Merative Explorys Dataset, focusing on electronic health record data of patients diagnosed with DCM and sleep disorders identified via ICD codes. Comorbidities analyzed included depression/bipolar disorder, chronic pulmonary disease, migraine, osteoarthritis, hypertension, malignancy, diabetes, and cerebrovascular disease. Patient demographic information (age, race, sex, and body mass index (BMI)) was included as covariates. Logistic regression analyses were performed to evaluate the association between each comorbidity and the risk of sleep disturbance. Results: Among 40,551 DCM patients, significant predictors of sleep disturbance included higher BMI (OR: 1.05, 95% CI: 1.05–1.06), depression/bipolar disorder (OR: 1.65, 95% CI: 1.56–1.74), chronic pulmonary disease (OR: 1.26, 95% CI: 1.20–1.33), migraine (OR: 1.32, 95% CI: 1.22–1.43), and hypertension (OR: 1.16, 95% CI: 1.10–1.23). Conclusions: This large-scale analysis demonstrates the multifactorial nature of sleep disturbances in DCM, highlighting strong associations with BMI and respiratory conditions, suggesting a contributory role of sleep-disordered breathing. The identification of migraines as a risk factor highlights the need for multidisciplinary management. Addressing modifiable risk factors such as BMI and mental health may improve sleep quality in DCM patients.

21 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
FAFaraz Arkam
Faraz Arkam
XZXianqi Zeng
Xianqi Zeng
EGEliana Goldstein
Eliana Goldstein
JBJetan Badhiwala
Jetan Badhiwala
ACAndrew K. Chan
Andrew K. Chan
JGJacob K. Greenberg
Jacob K. Greenberg
Objective: Cervical spondylotic myelopathy (CSM) is the most common cause of nontraumatic spinal cord dysfunction in adults. For mild disease, guidelines recommend shared decision-making between surgery and structured rehabilitation, yet no comparative effectiveness study has reported outcomes in this population. Whether a randomized trial is feasible is unknown. Methods: We conducted two cross-sectional surveys between December 2025 and July 2026: one of patients with surgeon-confirmed CSM of any severity, recruited from academic outpatient spine clinics, and one of practicing neurosurgical and orthopedic spine surgeons. Respondents rated willingness to participate in (1) a randomized trial of early surgery versus observation and (2) a prospective observational study in which treatment was patient selected. Responses of likely or very likely were classified as willing. Groups were compared using Fisher exact tests, designs within respondents using exact McNemar tests, and predictors using univariable logistic regression. Results: Fifty-six patients and 52 surgeons completed the surveys. Patients were markedly less willing than surgeons to accept randomization (16 of 56, 28.6% versus 44 of 52, 84.6%; p < 0.001). Both groups accepted the observational design (41 of 56, 73.2% versus 51 of 52, 98.1%; p < 0.001), and 27 of 40 patients unwilling to be randomized were willing to enroll in an observational study (p < 0.001). Willingness to be randomized did not differ across mJOA severity (mild 29.2%, moderate 25.0%, severe 33.3%; p = 0.93). Among patients declining randomization, 85.2% cited a wish to retain control over treatment, whereas fear of surgery was cited by one respondent. Forty-five surgeons (86.5%) considered both surgery and observation reasonable, and preference was divided (46.2% favoring early surgery, 48.1% favoring initial observation). Conclusions: Surgeon responses were consistent with equipoise, and most surgeons were willing to randomize, but most patients would decline random allocation, citing a wish to retain treatment choice rather than fear or distrust. A prospective observational study appears as the more feasible route to comparative evidence in mild CSM. Feasibility assessments restricted to clinicians may overestimate attainable accrual.

18 August 2026 in Neurosurgery
Verified
Journal Article
Closed access
SYSalim Yakdan
Salim Yakdan
ZXZiqi Xu
Ziqi Xu
JZJingwen Zhang
Jingwen Zhang
FAFaraz Arkam
Faraz Arkam
TRThomas L. Rodebaugh
Thomas L. Rodebaugh
JGJacob K. Greenberg
Jacob K. Greenberg
BACKGROUND AND OBJECTIVES: Accurately identifying candidates likely to benefit from surgery and addressing modifiable preoperative risk factors are central to optimizing outcomes. Current prediction tools often rely on static clinical data and patient-reported measures, which lack granularity for precision risk stratification. This study aims to determine whether preoperative mobile health (mHealth) assessments combining ecological momentary assessment (EMA) and wearable biometric monitoring improve prediction of postoperative outcomes after lumbar spine surgery. METHODS: Patients aged 21 to 85 years undergoing elective lumbar surgery for degenerative disease were enrolled up to 30 days before surgery. Participants completed EMA surveys up to 5 times daily for pain, disability, depression, and catastrophizing. Fitbit devices recorded activity and physiological data continuously. Participants also completed one-time retrospective self-report measures. Primary outcomes were achievement of substantial clinical benefit (SCB) at 12 months in Patient-Reported Outcomes Measurement Information System Pain Interference and disability scores. Secondary outcomes included SCB in Patient-Reported Outcomes Measurement Information System Physical Function and Numeric Rating Scale for leg and back pain. Predictive machine learning models were developed and evaluated using area under the receiver operating characteristic curve and precision-recall curve. Models using only one-time retrospective self-report data were compared with models incorporating mHealth features. RESULTS: Of 184 enrolled patients, 138 had sufficient data and were included in the analysis. Participants [median age, 62.4 years (IQR, 13.9); 55% female] completed 10 387 EMA surveys with a median of 78 responses per participant (IQR, 33.5). At 12-month, SCB was achieved by 66 patients for pain interference, 80 for disability, 81 for physical function, 81 for leg pain, and 89 for back pain. Compared with traditional models, mHealth models improved area under the receiver operating characteristic curve by 18.3% to 32.1% across outcomes. CONCLUSION: Preoperative mHealth assessments improve prediction of surgical outcomes compared with traditional assessments. If validated further, this workflow could enhance patient selection and outcome prediction.

13 February 2026 in European Spine Journal
Verified
Journal Article
Open access
PDF file
KJKaran Joseph Karan Joseph
Karan Joseph Karan Joseph
SYSalim Yakdan
Salim Yakdan
FGFrancisco Narro Garcia
Francisco Narro Garcia
JGJeffrey T. Galla
Jeffrey T. Galla
AYAlexander Thomas Yahanda
Alexander Thomas Yahanda
CMCamilo A. Molina
Camilo A. Molina
Purpose: As the prevalence of adult spinal deformity (ASD) increases, it is crucial to define patient-centered outcome benchmarks to improve understanding of successful surgical intervention. The Patient-Reported Outcomes Measurement Information System Pain Interference (PROMIS PI) is the gold standard for spine surgery, but substantial clinical benefit (SCB) thresholds specific to ASD patients remain undefined. This study aims to establish PROMIS PI SCB values using fixed and dynamic Oswestry Disability Index (ODI) anchors. Methods: This single-center retrospective cohort study included 117 ASD patients who underwent surgery for ASD from 2016 to 2024. PROMIS PI and ODI scores were collected preoperatively and at 6 months postoperatively. The SCB thresholds for PROMIS PI were calculated using both fixed (ODI > 19) and dynamic (≥ 50% improvement) anchors. Optimal cutoffs were identified using receiver operating characteristic (ROC) curves and clinical relevance was assessed using multivariable regressions of the association between the SCB thresholds and PROMIS Physical Function, Depression, and Anxiety scores. Results: PROMIS PI SCB thresholds with a fixed anchor were identified to be 9.6 points (AUC = 0.8563) or a 12.04% improvement when using a dynamic threshold (AUC = 0.8532). When using a dynamic anchor, the SCB thresholds were 8.2 points (AUC = 0.8185) or a 21.24% improvement when using a dynamic threshold (AUC = 0.855). Achieving SCB was associated with significantly greater improvements in physical function (β = 7.1 to 8.6, p < 0.001)) and depression (β=-4.6 to -5.1, p < 0.02) at one year. Conclusion: This is the first study to define ASD-specific SCB thresholds for PROMIS PI. We found that using a 21.24% improvement using a dynamic ODI anchor was a significant and clinically applicable benchmark. These findings will help enhance interpretability of PROMIS PI scores for evaluating surgical outcomes for managing ASD.